Effects of nucleoside transport inhibition on hepatosplanchnic perfusion, oxygen extraction capabilities, and tnf release during acute endotoxic shock

Shock

Volumn 15, Issue 5, 2001, Pages 378-385

  Zhang, Haibo ^a   De Jongh, Raf ^b   Cherkaoui, Soumaya ^b   Shahram, Mach ^b   Vray, Bernard ^c   Vincent, Jean Louis ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ERASME HOSPITAL   (Belgium)

^c NONE

Author keywords

Adenosine; Kidney; Liver; Low flow; Oxygen uptake; Sepsis

Indexed keywords

NUCLEOSIDE; OXYGEN;

ANIMAL; ARTICLE; DOG; FEMALE; KIDNEY; LIVER; MALE; METABOLISM; PATHOPHYSIOLOGY; REPERFUSION INJURY; SEPTIC SHOCK; TRANSPORT AT THE CELLULAR LEVEL; VASCULARIZATION;

ANIMALS; BIOLOGICAL TRANSPORT; DOGS; FEMALE; KIDNEY; LIVER; MALE; NUCLEOSIDES; OXYGEN; REPERFUSION INJURY; SHOCK, SEPTIC;

EID: 0035348193     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115050-00008     Document Type: Article

References (41)

1. Berne RM, Rubio R, Dobson JGJ, Curnish RR: Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ Res 28-29:1115-1119, 1971.
2. Lautt WW: The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 74:223-233, 1996.
3. Granger DN, Valleau JD, Parker RE, Lane RS, Taylor AE: Effects of adenosine on intestinal hemodynamics, oxygen delivery and capillary fluid exchange. Am J Physiol 235:H707-H719, 1978.
4. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA: Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153:4159-4169, 1994.
5. Firestein GS, Boyle D, Bullough DA, Gruber HE, Sajjadi FG, Montag A, Sambol B, Mullane KM: Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol 152:5853-5859, 1994.
6. Rosengren S, Bong GW, Firestein GS: Antiinflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leakage. J Immunol 154:5444-5450, 1995.
7. Thiel M, Chouker A: Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes. J Lab Clin Med 126:275-282, 1995.
8. Bardenheuer H, Thiel M: The biological role of adenosine for the cellular function during sepsis. In Messmer K (ed): Capillary Function and White Cell Interaction: Progress in Applied Microcirculation. Vol. 18. Basel: Karger, pp 112-131, 1991.
9. Van Belle H, Janssen PAJ: Comparative pharmacology of nucleoside transport inhibitors. Nucleosides Nucleotides 10:975-985, 1991.
10. Deussen A, Stappert M, Schafer S, Keim M: Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient. Circulation 99:2041-2047, 1999.
11. 2 supply dependence. J Appl Physiol 72:1499-1505, 1992.
12. Bonner RF, Clem TR, Bowen PD, Bowman RL: Laser Doppler continuous real-time minitor of pulsatile and mean blood flow in tissue microcirculation. In Chen SH, Chu B, Nossal R (eds): Scattering Techniques, Applied to Supramolecular and Nonequilibrium Systems. New York: Plenum, pp 685-702, 1981.
13. Zhang H, Spapen H, Manikis P, Rogiers P, Metz G, Buurman WA, Vincent J-L: Tirilazad mesylate (U74006F) inhibits effects of endotoxin in dogs. Am J Physiol 268:H1847-H1855, 1995.
14. 2 delivery from experimental data: sensitivity to error. J Appl Physiol 64:2074-2082, 1988
15. Borst MM, Schrader J: Adenine nucleotide release from isolated perfused gunine pig hearts and extracellular formation of adenosine. Circ Res 68:797-806, 1991.
16. Fredholm BB, Dunwiddie TV: How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-134, 1988.
17. Ohisalo JJ, Stouffer JE: Adenosine, thyroid status and regulation of lipolysis. Biochem J 178:249-251, 1979.
18. Kien M, Belamarich FA, Shepro D: Effects of adenosine and related compounds on thrombocyte and platelet aggregation. Am J Physiol 220:604-608, 1971.
19. de la Harpe, Nathan CF: Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces. J Immunol 143:596-602, 1989.
20. Van Belle H: Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res 27:68-76, 1993.
21. Van Belle H: Specific metabolically active anti-ischemic agents: adenosine and nucleoside transport inhibitors. In Singh BN, Dzau VJ, Vanhoutte PM, Woosley RL (eds): Cardiovascular Pharmacology and Therapeutics. New York: Churchill Livingstone, pp 217-235, 1993.
22. Rongen GA, Smits P, Ver Donck K, Willemsen JJ, De Abreu RA, Van Belle H, Thien T: Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans: implications for its future role in cardioprotection. J Clin Invest 95:658-668, 1995.
23. Schmidt H, Weigand MA, Li C, Schmidt W, Martin E, Bardenheuer HJ: Intestinal formation of hypoxanthine and uric acid during endotoxemia. J Surg Res 71:61-66, 1997.
24. Knight RJ, Bowmer CJ, Yates MS: Effect of the selective A1 adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine on acute renal dysfunction induced by Escherichia coli endotoxin in rats. J Pharm Pharmacol 45:979-984, 1993.
25. Van Belle H: In vivo effects of inhibitors of adenosine uptake. In Paton DM (ed): Adenosine and Adenine Nucleotides: Physiology and Pharmacology. London: Taylor and Francis, 251-258, 1988.
26. Rongen GA, Smits P, Bootsma G, Ver Donck K, de Vries A, Thien T: High-grade nucleoside transport inhibition stimulates ventilation in humans. J Clin Pharmacol 35:357-361, 1995.
27. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 249:G549-G556, 1985.
28. Lautt WW, D'Almeida MS, McQuaker J, D'Aleo L: Impact of the hepatic arterial buffer response on splanchnic vascular responses to intravenous adenosine, isoproterenol, and glucagon. Can J Physiol Pharmacol 66:807-813, 1988.
29. Shepherd AP, Riedel GL, Maxwell LC, Kiel JW: Selective vasodilators redistribute intestinal blood flow and depress oxygen uptake. Am J Physiol 247:G377-G384, 1984.
30. Motew SJ, Mourelatos MG, Miller RN, Ferguson JL, Law WR. Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats. Shock 7:439-446, 1997.
31. Lautt WW, Leagre DJ: The use of 8-phenyltheophylline as a competitive antagonist of adenosine and an inhibitor of the intrinsic regulatory mechanism of the hepatic artery. Can J Physiol Pharmacol 63:717-722, 1985.
32. Thompson CI, Spielman WS: Renal hemodynamic effects of exogenously administered adenosine and polyadenylic acid. Am J Physiol 263:F816-F823, 1992.
33. Churchill PC, Bidani AK: Adenosine and renal function. In Williams M (ed). Adenosine and Adenosine Receptors. Clifton, NJ: Human Press, pp 335-380, 1990.
34. Booster MH, Yin M, Maessen JG, Stubenitsky BM, Wijnen RM, Kootstra G: Protection of canine renal grafts by renin-angiotensin inhibition through nucleoside transport blockade. Transpl Int 8:207-213, 1995.
35. 2 uptake in isolated working dog muscle. J Appl Physiol 76:2820-2824, 1994.
36. Todo S, Zhu Y, Zhang S, Jin MB, Ishizaki N, Tanaka H, Subbotin V, Starzl TE: Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 63:217-223, 1997.
37. Thiel M, Kreimeier U, Holzer K, Moritz S, Peter K, Messmer K: Effects of adenosine on cardiopulmonary functions and oxygen-derived variables during endotoxemia. Crit Care Med 26:322-337, 1998.
38. Thiel M, Holzer K, Kreimeier U, Moritz S, Peter K, Messmer K: Effects of adenosine on the functions of circulating polymorphonuclear leukocytes during hyperdynamic endotoxemia. Infect Immun 65:2136-2144, 1997.
39. Dobson JG Jr: Mechanism of adenosine inhibition of catecholamine-induced response in heart. Circ Res 52:151-160, 1983.
40. Koga S, Morris S, Ogawa S, Liao H, Bilezikian JP, Chen G, Thompson WJ, Ashikaga T, Brett J, Stern DM: TNF modulates endothelial properties by decreasing cAMP. Am J Physiol 268:C1104-C1113, 1995.
41. LaMonica DA, Frohloff N, Dobson JG Jr. Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase. Am J Physiol 248:H737-H744, 1985.